3-52435690-G-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_020163.3(SEMA3G):​c.2262C>G​(p.Ser754Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)

Consequence

SEMA3G
NM_020163.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.00300

Publications

0 publications found
Variant links:
Genes affected
SEMA3G (HGNC:30400): (semaphorin 3G) The transcription of this gene is activated by PPAR-gamma, and the resulting protein product plays a role in endothelial cell migration. Expression of this gene also inhibits tumor cell migration and invasion. [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.059064686).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SEMA3GNM_020163.3 linkc.2262C>G p.Ser754Arg missense_variant Exon 16 of 16 ENST00000231721.7 NP_064548.1 Q9NS98
SEMA3GXM_024453642.2 linkc.2316C>G p.Ser772Arg missense_variant Exon 17 of 17 XP_024309410.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SEMA3GENST00000231721.7 linkc.2262C>G p.Ser754Arg missense_variant Exon 16 of 16 1 NM_020163.3 ENSP00000231721.2 Q9NS98

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 17, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2262C>G (p.S754R) alteration is located in exon 16 (coding exon 16) of the SEMA3G gene. This alteration results from a C to G substitution at nucleotide position 2262, causing the serine (S) at amino acid position 754 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.013
T
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.20
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.72
T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.059
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.90
L
PhyloP100
0.0030
PrimateAI
Benign
0.48
T
PROVEAN
Benign
0.11
N
REVEL
Benign
0.13
Sift
Benign
0.26
T
Sift4G
Benign
0.59
T
Polyphen
0.0030
B
Vest4
0.17
MutPred
0.39
Gain of glycosylation at S754 (P = 0.0016);
MVP
0.85
MPC
0.24
ClinPred
0.058
T
GERP RS
1.9
Varity_R
0.077
gMVP
0.19
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr3-52469706; API